For Immediate Release
Chicago, IL – July 14, 2017 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Crescent Point Energy Corporation (NYSE: (CPG - Free Report) – Free Report ), Vertex Pharmaceuticals Incorporated (NASDAQ: (VRTX - Free Report) – Free Report ), SodaStream International Ltd. (NASDAQ: (SODA - Free Report) – Free Report ), Commercial Vehicle Group Inc. (NASDAQ: (CVGI - Free Report) – Free Report ) and Melco Crown Entertainment Limited (NASDAQ: (MLCO - Free Report) – Free Report ).
Today, Zacks is promoting its ''Buy'' stock recommendations. Get #1Stock of the Day pick for free .
Here are highlights from Friday’s Analyst Blog:
5 Companies That Consistently Beat on Earnings
As we approach the beginning of earnings season, it is important to remember that earnings estimate revisions and projections are extremely important in determining the Zacks Rank, and quarterly earnings reports have the ability to greatly affect a stocks financial outlook and a company’s future potential.
Zacks customers can utilize our Stock Screener to search for companies that have consistently surprised and beaten earnings projections in recent quarters. Companies that are constantly able to defeat its earnings projections usually exhibit effective management, stronger upward momentum, and more impressive future outlooks.
As many earnings reports begin to be released, check out these 5 stocks that are projected to beat earnings estimates once again this quarter:
1. Crescent Point Energy Corporation (NYSE:(CPG - Free Report) – Free Report )
Crescent Point Energy Corporation is engaged in the acquisition, exploration and development of oil and natural gas properties in Western Canada. Notably, Crescent Point has demolished its earnings estimates in each of its past nine operational quarters by a whopping average of 629.97%. Not surprisingly, the company features an “A” grade for Growth and a “B” grade for Value on our Style Scoring System. In essence, Crescent Point exhibits ample opportunities for growth, while the company is currently viewed as undervalued.
Crescent Point pays its shareholders an impressive 3.70% dividend yield, which is intriguing to investors seeking income stocks. Furthermore, Crescent Point holds a projected EPS growth of 94.23% and $3.22 cash flow per share, both of which compare favorably to the industry averages of 82.22% and $0.34, respectively. Additionally, the company possesses a solid price/sales ratio of 1.56, which fares well against the industry average. Crescent Point Energy was recently promoted to a Zacks Rank #1 (Strong Buy).
2. Vertex Pharmaceuticals Incorporated (NASDAQ:(VRTX - Free Report) – Free Report )
Vertex Pharmaceuticals Incorporated discovers, develops, and market small molecule drugs that address major unmet medical needs. The company has defeated its earnings estimates in seven of its past nine operational quarters by an average of 27.39%. Additionally, the firm features a current Earnings ESP of 16.67%, which means that Vertex Pharmaceuticals is more likely to surprise this earnings season. Also, as of 60 days ago, Vertex has witnessed its full-year EPS estimates increase by an impressive 22.50% to $0.49.
Vertex Pharmaceutical possesses an “A” grade for Growth and “B” grade for Momentum, which means that the company holds excellent growth prospects while its share price has performed well recently. In fact, Vertex’s share price has increased by 49.74% over the past year. Vertex also boasts an astronomical projected EPS growth of 492.21% and respectable projected sales growth of 27.33%. Vertex Pharmaceuticals currently sits at a Zacks Rank #1 (Strong Buy).
3. SodaStream International Ltd. (NASDAQ:(SODA - Free Report) – Free Report )
SodaStream International is engaged in the manufacture of home beverage carbonation systems, which enable consumers to transform ordinary tap water into carbonated soft drinks and sparkling water. SodaStream has beaten its earnings projections in each of its past six operational quarters by an average of 103.29%. Additionally, SodaStream operates in the discretionary consumer products industry that currently sits in the top 25% of the Zacks Industry Rank.
The company sports an “A” grade for Growth, which means that the firm is anticipated to continue expanding. SodaStream features a current cash flow growth of 65.86% and net margin of 10.83%, which defeat the industry averages of 17.115 and 1.04%, respectively. Furthermore, the company boasts an excellent 3.54 current ratio and 31.14 cash/price ratio, both of which demolish industry averages. SodaStream International was recently promoted to a Zacks Rank #1 (Strong Buy) prior to earnings season.
4. Commercial Vehicle Group Inc. (NASDAQ:(CVGI - Free Report) – Free Report )
Commercial Vehicle Group Inc. supplies interior systems, vision safety solutions and other cab-related products for the global commercial vehicle market. Commercial Vehicle Group has defeated its earnings projections in each of its past four operational quarters by an astounding average of 173.61%. Nevertheless, the company sports a beta rating of 0.65, and the firm also belongs to a group of businesses in the top 6% on the Zacks Sector Rank.
Commercial Vehicle’s share price has performed well recently, increasing by a whopping 93.60% over the past year. Additionally, the company holds a projected EPS growth of 41.38% and price/book ratio of 3.81, which fare well against the industry averages of 8.54% and 2.59, respectively. Finally, Commercial Vehicle Group supports a solid price/sales ratio of 0.39. Commercial Vehicle Group possesses a Zacks Rank #1 (Strong Buy).
5. Melco Crown Entertainment Limited (NASDAQ:(MLCO - Free Report) – Free Report )
Melco Crown Entertainment Limited is a developer, owner and operator of casino gaming and entertainment casino resort facilities primarily in Asia. Similarly, Melco Crown has been consistent in beating earnings estimates; it has accomplished this feat in each of its past six operational quarters by an average of 106.95%. Also, as of 60 days ago, Melco Crown’s full-year EPS estimates were revised and increased by 5.80% to $0.73.
Melco Crown pays its shareholders a respectable 1.07% dividend yield. The company boasts a projected sales growth of 12.16% and cash flow per share of $1.61, both of which compare favorably to the industry averages of 1.10% and $1.06, respectively. Melco Crown Entertainment Limited was recently promoted to a Zacks Rank #1 (Strong Buy).
Strong Stocks that Should Be in the News
Many are little publicized and fly under the Wall Street radar. They're virtually unknown to the general public. Yet today's 220 Zacks Rank #1 "Strong Buys" were generated by the stock-picking system that has nearly tripled the market from 1988 through 2015. Its average gain has been a stellar +26% per year. See these high-potential stocks free >>.
Get the full Report on CPG - FREE
Get the full Report on VRTX - FREE
Get the full Report on SODA - FREE
Get the full Report on CVGI - FREE
Get the full Report on MLCO - FREE
Follow us on Twitter: https://twitter.com/zacksresearch
Join us on Facebook: https://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts
Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.
Zacks Investment Research
800-767-3771 ext. 9339
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.